TOKYO, Feb. 18 /PRNewswire/ -- CLONTECH Laboratories Japan today announced
the appointment of Mr. Junya Tominaga as President and the move to their new
offices on March 1, 1999.
Dr. Kenneth Fong, CEO of CLONTECH Laboratories, Inc. headquarters in Palo
Alto, California , announced that Mr. Junya Tominaga will manage the sales and
marketing, technical support services, distribution channels and scientific
collaborations of CLONTECH Laboratories Japan Ltd.
Dr. Fong indicates that:
"Mr. Tominaga has excellent contacts in the Japanese scientific community,
both among customers and other companies, having worked in this field for the
past 20 years."
A veteran of the life sciences industry, Mr. Tominaga spent the past six
years as President of Molecular Dynamics Japan ; prior to that, he was
President of Tomy Corporation, the MD distributor in Japan and a subsidiary of
Tomy Seiko Inc.
He received his Engineering Degree from Hosei University and has lived and
studied in England and also worked in the US.
In addition to the announcement of Mr. Tominaga, beginning March 1st, 1999
CLONTECH Japan will move its offices and distribution activities to:
2-1-9 Shinkawa, Chuo-Ku, Tokyo
1F: Shipping Center
6F: New Offices
Technical Support: 03-3523-9609
Order Desks: 03-3523-9780
Web Site: http://www.clontech.co.jp.
Order FAX: -9781
Mr. Hiroyuki Masumoto, CLONTECH Laboratories' International Sales Manager
"The new offices and distribution center will enable the company to have
enough inventory on-hand to improve the next day's delivery service while the
well-trained technical support staff will be able to respond back immediately
to end-user inquiries."
Mr. Masumoto further indicates that "the Japanese-language catalog and
other printed materials, seminars and web-site will enable local customers to
communicate more effectively and directly with the staff in the Tokyo
About the Company
Headquartered in Palo Alto, California, CLONTECH Laboratories
(www.clontech.com) is a provider of innovative enabling technologies to the
life sciences research market. Using their expertise in several areas
including PCR, genetic reporter systems, RNA technology, gene expression
systems, and differential gene expression, the Company produces a wide range
of innovative biological systems, kits, and support products that have proven
to be highly valuable tools in fields like drug discovery, cancer research,
neurobiology, pharmacology, cell biology, genomics and functional genomics.
SOURCE CLONTECH Laboratories, Inc.